Cargando…
Multicentre, retrospective study of the efficacy and safety of nivolumab for recurrent and metastatic salivary gland carcinoma
Although immune-checkpoint inhibitors (ICIs) are effective against various cancers, little is known regarding their role in salivary gland carcinoma (SGC) treatment. Therefore, we evaluated the efficacy and safety of nivolumab monotherapy in patients with recurrent and/or metastatic SGC. In this mul...
Autores principales: | Niwa, Kazutomo, Kawakita, Daisuke, Nagao, Toshitaka, Takahashi, Hideaki, Saotome, Takashi, Okazaki, Masashi, Yamazaki, Keisuke, Okamoto, Isaku, Hirai, Hideaki, Saigusa, Natsuki, Fushimi, Chihiro, Masubuchi, Tatsuo, Miura, Kouki, Okazaki, Shin-ichi, Matsui, Hirooki, Okada, Takuro, Iwaki, Sho, Matsuki, Takashi, Hanyu, Kenji, Tsukahara, Kiyoaki, Oridate, Nobuhiko, Tada, Yuichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552420/ https://www.ncbi.nlm.nih.gov/pubmed/33046752 http://dx.doi.org/10.1038/s41598-020-73965-6 |
Ejemplares similares
-
Real-World, Long-Term Outcomes of Nivolumab Therapy for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck and Impact of the Magnitude of Best Overall Response: A Retrospective Multicenter Study of 88 Patients
por: Matsuki, Takashi, et al.
Publicado: (2020) -
Hematological predictive markers for recurrent or metastatic squamous cell carcinomas of the head and neck treated with nivolumab: A multicenter study of 88 patients
por: Matsuki, Takashi, et al.
Publicado: (2020) -
Postoperative Complications and Swallowing Function after Jejunal and Skin Flap Reconstruction for Hypopharyngeal Carcinoma—A Multicenter Retrospective Study
por: Tokashiki, Kunihiko, et al.
Publicado: (2022) -
Survival benefit of HER2-targeted or androgen deprivation therapy in
salivary duct carcinoma
por: Kawakita, Daisuke, et al.
Publicado: (2022) -
The Role of the EZH2 and H3K27me3 Expression as a Predictor of Clinical Outcomes in Salivary Duct Carcinoma Patients: A Large-Series Study With Emphasis on the Relevance to the Combined Androgen Blockade and HER2-Targeted Therapy
por: Saigusa, Natsuki, et al.
Publicado: (2022)